FDA Inspection 964462 — Novo Nordisk A/S
The FDA completed an inspection of Novo Nordisk A/S on Apr 8, 2016 in Bagsvard. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 8, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bagsvard (Denmark)